相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy
Peter-Paul M. Willemse et al.
EUROPEAN UROLOGY (2022)
Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance
P. Travis Courtney et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Active surveillance for intermediate-risk prostate cancer
Madhur Nayan et al.
WORLD JOURNAL OF UROLOGY (2022)
Active surveillance in favorable intermediate-risk prostate cancer patients: Predictors of deferred intervention and treatment choice
Rashid K. Sayyid et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2022)
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up
James A. Eastham et al.
JOURNAL OF UROLOGY (2022)
Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer The ENACT Randomized Clinical Trial
Neal D. Shore et al.
JAMA ONCOLOGY (2022)
Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis
Pawel Rajwa et al.
EUROPEAN UROLOGY (2021)
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for inter mediate risk prostate cancer patients
Jonathan B. Bloom et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Factors Associated With Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort
Lauren Folgosa Cooley et al.
JOURNAL OF UROLOGY (2021)
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review
Ekaterina Laukhtina et al.
WORLD JOURNAL OF UROLOGY (2021)
Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study
Arnas Rakauskas et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2021)
Active Surveillance-Is It Feasible for Intermediate-risk Localised Prostate Cancer?
Subhabrata Mukherjee et al.
EUROPEAN UROLOGY OPEN SCIENCE (2021)
Active surveillance in intermediate-risk prostate cancer
Laurence Klotz
BJU INTERNATIONAL (2020)
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
David E. Neal et al.
EUROPEAN UROLOGY (2020)
The long-term outcomes of Gleason grade groups 2 and 3 prostate cancer managed by active surveillance: Results from a large, population-based cohort
Patrick O. Richard et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2020)
Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)
Timothy J. Wilt et al.
EUROPEAN UROLOGY (2020)
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center
Sigrid Carlsson et al.
JOURNAL OF UROLOGY (2020)
Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes
Dmitry Enikeev et al.
CLINICAL GENITOURINARY CANCER (2020)
Active Surveillance for Localized Prostate Cancer: Nationwide Observational Study
Frederik B. Thomsen et al.
JOURNAL OF UROLOGY (2019)
Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United States
Jeremy B. Shelton et al.
UROLOGY (2019)
Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer
Santino S. Butler et al.
CANCER (2019)
Guidelines for Reporting of Statistics for Clinical Research in Urology
Melissa Assel et al.
EUROPEAN UROLOGY (2019)
Active surveillance for localized prostate cancer: update of a prospective single-center cohort
Mathias Thostrup et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2018)
Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance
Michael J. Whalen et al.
CLINICAL GENITOURINARY CANCER (2018)
Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer
Selma Masic et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Risk stratification: a tool to predict the course of active surveillance for localized prostate cancer?
Jan Herden et al.
BJU INTERNATIONAL (2017)
Adverse Disease Features in Gleason Score 3+4 Favorable Intermediate-Risk'' Prostate Cancer: Implications for Active Surveillance
Alessandro Morlacco et al.
EUROPEAN UROLOGY (2017)
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance
Yaw A. Nyame et al.
JOURNAL OF UROLOGY (2017)
Active Surveillance for Favorable Risk Prostate Cancer in African Caribbean Men: Results of a Prospective Study
Matthias Meunier et al.
JOURNAL OF UROLOGY (2017)
Identifying intermediate-risk candidates for active surveillance of prostate cancer
Richard Savdie et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Long-term Results of Active Surveillance in the Goteborg Randomized, Population-based Prostate Cancer Screening Trial
Rebecka Arnsrud Godtman et al.
EUROPEAN UROLOGY (2016)
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence
Adam I. Cole et al.
JOURNAL OF UROLOGY (2016)
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience
Hima Bindu Musunuru et al.
JOURNAL OF UROLOGY (2016)
Metastatic Prostate Cancer in Men Initially Treated with Active Surveillance
Toshihiro Yamamoto et al.
JOURNAL OF UROLOGY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Active Holistic Surveillance: The Nutritional Aspect of Delayed Intervention in Prostate Cancer
Courtney J. Berg et al.
JOURNAL OF NUTRITION AND METABOLISM (2016)
Observational studies and the natural history of screen-detected prostate cancer
Peter C. Albertsen
CURRENT OPINION IN UROLOGY (2015)
Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification
Stacy Loeb et al.
EUROPEAN UROLOGY (2015)
Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer
Stacy Loeb et al.
EUROPEAN UROLOGY (2015)
Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
Laurence Klotz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer
Meelan Bul et al.
BJU INTERNATIONAL (2012)
Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer
Matthew R. Cooperberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study
Par Stattin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Quality of life and satisfaction with outcome among prostate-cancer survivors
Martin G. Sanda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
分享论文
